MedTrace Logo

A Multicentre Observational Study to Assess Long-term Outcome of Participants in the EXCELLENT Clinical Trial

NCT06521047 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2024-09-25

No results posted yet for this study

Summary

The PERFECT study is an observational study designed to follow patients randomised in the EXCELLENT study (NCT02669810) for 10 years.

The aim is to assess the long-term clinical outcomes for patients randomised to the Standard of Care arm or the ProtheraCytes arm.

Conditions

  • Acute Myocardial Infarction

Interventions

OTHER

NA - Observational study

Observational study, data collection only.

Sponsors & Collaborators

  • CellProthera

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-20
Primary Completion
2034-03-15
Completion
2034-03-15

Countries

  • France
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06521047 on ClinicalTrials.gov